We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A novel synthetic bone graft showed noninferiority to ...

Xtant Medical had a busy 2025 with new product launches and sales. Six headlines to know: 1. Xtant Medical launched OsteoFactorPro, a naturally derived, growth factor-rich formulation for spine and ...

Here are 40 spine devices and technologies earning FDA clearances in 2025. Note: This is not an exhaustive list. 1. SurGenTec earned FDA 510(k) clearance for its OsteoFlo HydroFiber to be used as a ...

WESTMINSTER, Colo., Dec. 17, 2025 /CNW/ -- Cerapedics Inc., a global, commercial-stage orthopedics company dedicated to redefining the path to bone repair, today announced the publication of two ...

Approval underscores Cerapedics' commitment to investing in evidence that brings scientific rigor to bone grafting for spinal fusion. WESTMINSTER, Colo., Sept. 24, 2024 /PRNewswire/ -- Cerapedics Inc.

A tuberculosis outbreak that spanned seven states in 2023 has been tied to bone graft products from an infected donor — again. Two spinal surgery patients died from a tuberculosis infection, or TB, ...

(Reuters) - Two long-awaited independent reviews of a controversial Medtronic Inc bone growth product show it works as well as traditional bone grafts taken from patients, but it may not be as safe.

WESTMINSTER, Colo., Dec. 17, 2025 /PRNewswire/ -- Cerapedics Inc., a global, commercial-stage orthopedics company dedicated to redefining the path to bone repair, today announced the publication of ...

ASPIRE was a prospective, single-blinded, multicenter, randomized, controlled pivotal IDE study, that evaluated the safety and efficacy of PearlMatrix compared to use of local autograft bone graft ...